tradingkey.logo
tradingkey.logo
Search

Catheter Precision Inc

VTAK
Add to Watchlist
0.790USD
-0.085-9.83%
Close 07/02, 13:00ETQuotes delayed by 15 min
2.13MMarket Cap
LossP/E TTM

Catheter Precision Inc

0.790
-0.085-9.83%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

-9.83%

5 Days

-27.52%

1 Month

-22.55%

6 Months

-60.70%

Year to Date

-56.83%

1 Year

-82.12%

Key Figures
0.841Open
0.842High
252.87KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
9.39%Turnover Ratio
0.865Prev. Close
0.780Low
119.08KTurnover
LossP/E Static
0.22P/B
0.00%Div Yield TTM
-51.23%ROA
15.68152wk High
0.70Volume Ratio
-21.80MNet Profit
2.69MShares
-10.4776EPS TTM
-1.02Beta
-185.06%ROE
0.75052wk Low
7.12%Amplitude
90.28%Gross Margin
2.13MMarket Cap
-2.28Reward/Risk
6.68%Risk Rate

Key Insights

Catheter Precision Inc's fundamentals are relatively weak, and its growth potential is high.Its valuation is considered fairly valued, ranking 153 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 38.00.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Catheter Precision Inc's Score

Industry at a Glance

Industry Ranking
153 / 204
Overall Ranking
442 / 4565
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Catheter Precision Inc Highlights

StrengthsRisks
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 85.29% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 819.00K.
Undervalued
The company’s latest PE is -0.08, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 304.48K shares, increasing 43.06% quarter-over-quarter.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 6.93.

Analyst Rating

Based on 0 analysts
--
Current Rating
38.000
Target Price
+1753.66%
Upside Space

Catheter Precision Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Catheter Precision Inc Info

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
Ticker SymbolVTAK
CompanyCatheter Precision Inc
CEOJenkins (David A)
Websitehttps://www.ramed.com/

FAQs

What is the current price of Catheter Precision Inc (VTAK)?

The current price of Catheter Precision Inc (VTAK) is 0.79.

What is the symbol of Catheter Precision Inc?

The ticker symbol of Catheter Precision Inc is VTAK.

What is the 52-week high of Catheter Precision Inc?

The 52-week high of Catheter Precision Inc is 15.68.

What is the 52-week low of Catheter Precision Inc?

The 52-week low of Catheter Precision Inc is 0.75.

What is the market capitalization of Catheter Precision Inc?

The market capitalization of Catheter Precision Inc is 2.13M.

What is the Earnings Per Share (EPS TTM) of Catheter Precision Inc (VTAK)?

The Earnings Per Share (EPS TTM) of Catheter Precision Inc (VTAK) is -15.90.